On Invalid Date, Lixte Biotechnology Holdings (NASDAQ: LIXT) reported Q1 2023 earnings per share (EPS) of -$0.08, up 33.33% year over year. Total Lixte Biotechnology Holdings earnings for the quarter were -$1.37 million. In the same quarter last year, Lixte Biotechnology Holdings's earnings per share (EPS) was -$0.12.
As of Q2 2023, Lixte Biotechnology Holdings's earnings has grown year over year. Lixte Biotechnology Holdings's earnings in the past year totalled -$6.02 million.
What was LIXT's revenue last quarter?
On Invalid Date, Lixte Biotechnology Holdings (NASDAQ: LIXT) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Lixte Biotechnology Holdings's revenue was $0.00.
What was LIXT's revenue growth in the past year?
As of Q2 2023, Lixte Biotechnology Holdings's revenue has grown null year over year. Lixte Biotechnology Holdings's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.